Taken together, these functional studies suggested a novel molecular mechanism that interaction of glucocorticoids-GR and L-PGDS-PGD2-DP1-pERK signaling pathway underpins the neuroprotective effects of dexamethasone pretreatment on neonatal HI brain injury (Figure 6). The gene discussed is HPGDS; the disease is injury.